Stay updated with breaking news from Paul Stuka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a report released on Thursday. The firm issued a sell rating on the stock. A number of other research analysts also recently commented on NSPR. Alliance Global Partners lowered their price target on shares of InspireMD from $5.15 to $4.75 in a report […]
StockNews.com started coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock. NSPR has been the subject of a number of other research reports. Piper Sandler started coverage on shares of InspireMD in a research note on Monday, June 12th. […]
StockNews.com started coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a report released on Monday. The brokerage issued a sell rating on the stock. A number of other research analysts have also issued reports on the company. Piper Sandler began coverage on InspireMD in a research report on Monday, June 12th. They set […]
StockNews.com started coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a research note published on Monday. The firm issued a sell rating on the stock. NSPR has been the subject of a number of other reports. Piper Sandler began coverage on shares of InspireMD in a research report on Monday, June 12th. They […]
Investment analysts at StockNews.com started coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock. Several other research analysts also recently commented on the company. Alliance Global Partners cut their target price on InspireMD from $5.15 to $4.75 […]